Company intelligence / Profile preview

Us2.ai

Singapore, Singapore

Ownership: Private
Development stage: Other

Overview

Us2.ai's AI-powered software automates echocardiography analysis, enhancing clinical decision-making and accessibility to heart health diagnostics. It has received FDA clearance and is expanding globally.

Therapeutic areas: CardiovascularRare Diseases
Modalities: AI-Driven SoftwareUltrasound Analysis
Industry: Medical Imaging

Partnerships

AstraZenecaJanssen PharmaceuticalsFujifilmBrigham and Women's Hospital

Beyond the preview

Go deeper on Us2.ai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Us2.ai.

Explore the full profile